T. Rowe Price Associates Portfolio holdings
T. Rowe Price Associates, Inc., founded in 1937 by Thomas Rowe Price, Jr., is a globally recognized investment management firm headquartered in Baltimore, Maryland, known for its disciplined, research-driven approach to active investing. The company manages hundreds of billions in assets, offering a wide range of mutual funds, retirement plans, and advisory services tailored to individual investors, institutions, and financial intermediaries. Emphasizing long-term growth and a conservative investment philosophy, T. Rowe Price has built a strong reputation for its equity and fixed-income funds, often focusing on fundamental analysis to identify undervalued opportunities. Still publicly traded and independent, it remains a trusted name in the industry, balancing tradition with innovation to meet evolving client needs.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Rivian
RIVN
|
+$18.7B |
| 2 |
Apple
AAPL
|
+$5.48B |
| 3 |
NVIDIA
NVDA
|
+$5.33B |
| 4 |
Tesla
TSLA
|
+$4.47B |
| 5 |
Microsoft
MSFT
|
+$2.15B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Visa
V
|
+$4.26B |
| 2 |
Meta Platforms (Facebook)
META
|
+$3.3B |
| 3 |
Morgan Stanley
MS
|
+$2.82B |
| 4 |
Global Payments
GPN
|
+$2.43B |
| 5 |
PayPal
PYPL
|
+$2B |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 27.36% |
| 2 | Healthcare | 16.09% |
| 3 | Consumer Discretionary | 15.79% |
| 4 | Communication Services | 12.38% |
| 5 | Financials | 10.76% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2451
Cenovus Energy
CVE
$56.4B
| $430K | ﹤0.01% |
35,024
| – | – |
|
|
TDAY
2452
USA Today Co
TDAY
$1B
| $430K | ﹤0.01% |
80,613
-2,647
| -3% | -$14.8K |
|
2453
Castle Biosciences
CSTL
$933M
| $426K | ﹤0.01% |
9,944
+3,209
| +48% | +$168K |
|
2454
Dyne Therapeutics
DYN
$4.85B
| $425K | ﹤0.01% |
35,758
-600
| -2% | -$8.43K |
|
2455
Valaris
VAL
$5.91B
| $425K | ﹤0.01% |
11,800
-1,300
| -10% | -$45.3K |
|
|
VXRT
2456
DELISTED
Vaxart
VXRT
| $423K | ﹤0.01% |
67,397
-10,637
| -14% | -$72.6K |
|
2457
Andersons Inc
ANDE
$2.21B
| $422K | ﹤0.01% |
10,913
-601
| -5% | -$21.1K |
|
2458
Unisys
UIS
$210M
| $422K | ﹤0.01% |
20,539
-1,097
| -5% | -$24.1K |
|
|
LADR
2459
Ladder Capital
LADR
$1.27B
| $421K | ﹤0.01% |
35,150
-5,977
| -15% | -$70.9K |
|
2460
Motorcar Parts of America
MPAA
$235M
| $421K | ﹤0.01% |
24,676
-314
| -1% | -$5.9K |
|
2461
Napco Security Technologies
NSSC
$1.37B
| $421K | ﹤0.01% |
16,860
-4,200
| -20% | -$99.1K |
|
|
ZEUS
2462
DELISTED
Olympic Steel
ZEUS
| $421K | ﹤0.01% |
17,904
+1,700
| +10% | +$41.1K |
|
2463
Columbus McKinnon
CMCO
$550M
| $420K | ﹤0.01% |
9,084
-477
| -5% | -$23K |
|
|
POLY
2464
DELISTED
Plantronics, Inc.
POLY
| $420K | ﹤0.01% |
14,315
-645
| -4% | -$17.8K |
|
|
DHC
2465
Diversified Healthcare Trust
DHC
$2.03B
| $419K | ﹤0.01% |
135,540
-9,447
| -7% | -$30.5K |
|
2466
Daily Journal
DJCO
$828M
| $416K | ﹤0.01% |
1,166
-17
| -1% | -$6K |
|
2467
World Acceptance Corp
WRLD
$875M
| $415K | ﹤0.01% |
1,690
-82
| -5% | -$17.8K |
|
2468
State Street SPDR S&P MIDCAP 400 ETF Trust
MDY
$27.3B
| $414K | ﹤0.01% |
800
| – | – |
|
|
WLL
2469
DELISTED
Whiting Petroleum Corporation
WLL
| $413K | ﹤0.01% |
+6,383
| New | +$418K |
|
2470
Collegium Pharmaceutical
COLL
$913M
| $412K | ﹤0.01% |
22,047
-600
| -3% | -$11.7K |
|
2471
The Greenbrier Companies
GBX
$1.42B
| $412K | ﹤0.01% |
8,969
-2,015
| -18% | -$87.4K |
|
|
DCUE
2472
DELISTED
Dominion Energy, Inc. 2019 Series A Corporate Units
DCUE
| $411K | ﹤0.01% |
4,100
+833
| +25% | +$82.6K |
|
2473
Peabody Energy
BTU
$2.94B
| $410K | ﹤0.01% |
40,757
-638
| -2% | -$7.75K |
|
2474
Douglas Elliman
DOUG
$183M
| $409K | ﹤0.01% |
+37,347
| New | +$420K |
|
|
AAWW
2475
DELISTED
Atlas Air Worldwide Holdings, Inc.
AAWW
| $409K | ﹤0.01% |
4,350
-460
| -10% | -$39.6K |
|
Similar funds
T. Rowe Price Associates's Q4 2021 Portfolio in Review
As of Q4 2021, T. Rowe Price Associates held 3,121 positions worth $1.11T, up 4.6% from $1.06T the previous quarter. Its ten largest holdings account for 28% of the portfolio.
T. Rowe Price Associates's Q4 2021 filing shows 186 new, 817 increased, 1,825 reduced and 148 closed positions. Its largest new stake was Rivian: 162,080,423 shares worth $16.1B. The largest sale was Visa, an estimated $4.26B.
By sector, the portfolio is most concentrated in Technology at 27% of assets, up from 25% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- T. Rowe Price Associates's largest Q4 2021 buy was Rivian: 162,080,423 shares worth $16.1B.
- T. Rowe Price Associates added most to Apple in Q4 2021, an estimated $5.48B increase.
- T. Rowe Price Associates's biggest Q4 2021 reduction was Visa, cutting an estimated $4.26B.
- T. Rowe Price Associates fully exited Acceleron Pharma in Q4 2021, selling an estimated $923M.
- T. Rowe Price Associates's ten largest holdings make up 28% of its $1.11T portfolio in Q4 2021.
- T. Rowe Price Associates opened 186 new positions and closed 148 in Q4 2021.
- T. Rowe Price Associates's portfolio value rose 4.6% quarter-over-quarter to $1.11T.
Based on T. Rowe Price Associates's 13F filing for Q4 2021, filed 14 Feb 2022.